Back to Search
RACHEL STOREY, DO
DO
Family Medicine Physician
NPI: 1699121053Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
2017-02370(NC)
Research & Publications (20)
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
PMID 15668190·Thromb Res·2005
8-other
Mucosa associated lymphoid tissue lymphoma presenting within a solitary anti-mesenteric dilated segment of ileum: a case report.
PMID 19126231·J Med Case Rep·2009
8-other
Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
PMID 19103996·Circulation·2009
7-preclinical
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
PMID 19335707·Int J Clin Pract·2009
4-observational
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.
PMID 19637098·Platelets·2009
2-rct
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
PMID 19332184·Am Heart J·2009
3-trial
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
PMID 18297550·Platelets·2008
8-other
Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development.
PMID 18569859·Platelets·2008
6-review
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
PMID 17980250·J Am Coll Cardiol·2007
4-observational
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
PMID 17980251·J Am Coll Cardiol·2007
4-observational
An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.
PMID 17902293·South Med J·2007
5-case
An elusive paleodemography? A comparison of two methods for estimating the adult age distribution of deaths at late Classic Copan, Honduras.
PMID 17078034·Am J Phys Anthropol·2007
4-observational
Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients.
PMID 16767486·Eur J Clin Microbiol Infect Dis·2006
8-other
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.
PMID 16769602·Platelets·2006
3-trial
Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention.
PMID 16732379·Thromb Haemost·2006
3-trial
The effect of crystal morphology and mill type on milling induced crystal disorder.
PMID 16246535·Eur J Pharm Sci·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 19485 Old Jetton Rd, Suite 100
Cornelius, NC 28031 - Phone
- (704) 316-5170
Quick Facts
- NPI
- 1699121053
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile